Board Member
Napoleone Ferrara is the recipient of both the Lasker-DeBakey Award and the Breakthrough Prize in Life Sciences for his work developing Avastin and Lucentis, two multi-billion dollar therapies that transformed the treatment of cancer and wet macular degeneration.